feed,title,long_url,short_url
Benzinga,EXCLUSIVE: BioRestorative Therapies Gets Exclusive License Rights From Regenexx For Development Of BRTX-100 Disc Program To Treat Chronic Lumbar Disc Disease,https://benzinga.com/news/22/12/29953734/exclusive-biorestorative-therapies-gets-exclusive-license-rights-from-regenexx-for-development-of-br,https://bit.ly/3HggjFn
Benzinga,$65 Million Bet On Iovance Biotherapeutics? Check Out These 3 Stocks Insiders Are Buying,https://benzinga.com/trading-ideas/long-ideas/22/12/29954380/65-million-bet-on-iovance-biotherapeutics-check-out-these-3-stocks-insiders-are-buying,https://bit.ly/3VVteAB
